- Home
- FCO vs IOBT Comparison
FCO vs IOBT Comparison
Compare FCO & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCO
- IOBT
- Stock Information
- Founded
- FCO 1991
- IOBT 2014
- Country
- FCO United Kingdom
- IOBT Denmark
- Employees
- FCO N/A
- IOBT N/A
- Industry
- FCO Investment Managers
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- FCO Finance
- IOBT Health Care
- Exchange
- FCO Nasdaq
- IOBT Nasdaq
- Market Cap
- FCO 85.6M
- IOBT 79.7M
- IPO Year
- FCO N/A
- IOBT 2021
- Fundamental
- Price
- FCO $6.41
- IOBT $1.35
- Analyst Decision
- FCO
- IOBT Strong Buy
- Analyst Count
- FCO 0
- IOBT 3
- Target Price
- FCO N/A
- IOBT $9.33
- AVG Volume (30 Days)
- FCO 100.1K
- IOBT 209.9K
- Earning Date
- FCO 01-01-0001
- IOBT 08-12-2025
- Dividend Yield
- FCO 14.96%
- IOBT N/A
- EPS Growth
- FCO N/A
- IOBT N/A
- EPS
- FCO 0.43
- IOBT N/A
- Revenue
- FCO N/A
- IOBT N/A
- Revenue This Year
- FCO N/A
- IOBT N/A
- Revenue Next Year
- FCO N/A
- IOBT N/A
- P/E Ratio
- FCO $12.30
- IOBT N/A
- Revenue Growth
- FCO N/A
- IOBT N/A
- 52 Week Low
- FCO $4.73
- IOBT $0.66
- 52 Week High
- FCO $6.63
- IOBT $1.73
- Technical
- Relative Strength Index (RSI)
- FCO 60.54
- IOBT 60.38
- Support Level
- FCO $6.16
- IOBT $1.25
- Resistance Level
- FCO $6.41
- IOBT $1.57
- Average True Range (ATR)
- FCO 0.09
- IOBT 0.11
- MACD
- FCO -0.00
- IOBT -0.01
- Stochastic Oscillator
- FCO 82.14
- IOBT 68.29
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.